ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BMK Benchmark Holdings Plc

43.50
0.25 (0.58%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Benchmark Holdings Plc LSE:BMK London Ordinary Share GB00BGHPT808 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.25 0.58% 43.50 43.00 43.50 42.90 42.40 42.90 334,274 16:35:10
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 169.74M -23.15M -0.0313 -13.71 317.18M

Benchmark Holdings PLC Acquisition and Issue of Equity (7664C)

03/10/2018 7:00am

UK Regulatory


Benchmark (LSE:BMK)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Benchmark Charts.

TIDMBMK

RNS Number : 7664C

Benchmark Holdings PLC

03 October 2018

3 October 2018

Benchmark Holdings plc

("Benchmark", the "Company" or the "Group")

Acquisition and Issue of Equity

Acquisition of small data technology firm to support strategy of combining biology and technology to improve profitability for customers

Benchmark, the aquaculture health, advanced nutrition, and genetics business, announces that it has agreed to acquire the entire issued share capital of Videntis AS ("Videntis"), a provider of data technology to aquaculture and agriculture producers for an initial consideration of GBP150,000 and a total consideration of up to GBP300,000.

Videntis' technology enables producers to have real-time data and feedback on feed efficiency, welfare and product quality, supporting Benchmark's strategy of bringing together technology and biology to improve yield, quality and profitability for its customers.

Malcolm Pye, Chief Executive of Benchmark said:

"We have worked with Videntis for a number of years. Videntis' IP and expertise support our strategy of combining biology and technology to benefit our customers. Data technology is an increasingly important tool to maximise yield and to manage biological challenges. Combined with Benchmark's products it allows us to offer an integrated solution to our clients".

Terms of the acquisition

The initial consideration of GBP150,000 is to be satisfied by the issue of 246,700 ordinary shares to Videntis AS. These shares will be credited as fully paid and will rank pari passu in all respects with the existing ordinary shares of 0.1 pence each in the capital of the Company, including the right to receive all dividends and other distributions declared, made or paid on or in respect of such ordinary shares after the date of issue. Application has been made for these shares to be admitted to trading on AIM. It is expected that admission will become effective at 8.00 a.m. on 8 October 2018. Following the issue of these shares, the Company will have a total of 557,447,491 ordinary shares of 0.1 pence each with one voting right per share in issue, being the figure that may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company following admission. Further consideration of up to GBP150,000 in Benchmark shares will be payable, pursuant to an earn-out over the period from completion to 30 September 2020 if certain net profit targets are met.

About Videntis

Based in Norway, Videntis was founded in 2013 and has collaborated with Benchmark on the development of management systems for its fish veterinary laboratories and of "i-wise", a new health portal which allows vets, fish health companies and producers to visualise and interpret information on production and health across their sites. The portal is currently operational in Norway and Scotland, and will be operational in Chile in 2019.

   -      Ends      - 
 
 
    For further information, please contact: 
   Benchmark Holdings plc                     Tel: 020 7920 3150 
   Malcolm Pye, CEO 
   Ivonne Cantu, Investor Relations 
   Rachel Aninakwah, Communications 
 
 
    Numis                                      Tel: 020 7260 1000 
   Michael Meade / Freddie Barnfield (NOMAD) 
   James Black (Corporate Broking) 
 
 
    MHP                                        Tel: 020 3128 8742 
   Katie Hunt / Alistair de Kare-Silver       benchmark@mhpc.com 
 

Notes to Editors:

Benchmark challenges the status quo in aquaculture. Since 2000, Benchmark has consistently worked to build a technology-rich platform in the areas of genetics, advanced nutrition, animal health and knowledge services, to serve its customers, helping them take control of their biological environment to improve yield and efficiency in a sustainable way.

The Company has leading positions in its core markets and established R&D, manufacturing and distribution capabilities to serve all the major aquaculture markets. Benchmark operates in 27 countries in five continents and as at 31 March 2018, it employed 1028 people.

For further information on Benchmark please visit www.benchmarkplc.com / @WeAreBenchmark

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ACQEAEEAEADPFAF

(END) Dow Jones Newswires

October 03, 2018 02:00 ET (06:00 GMT)

1 Year Benchmark Chart

1 Year Benchmark Chart

1 Month Benchmark Chart

1 Month Benchmark Chart

Your Recent History

Delayed Upgrade Clock